We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Neuraxpharm

News List

Panaxia & AxioNovo GmbH to Market Cannabis-Based Products in Germany americanpharmaceuticalreview
July 30, 2021
Panaxia Labs Israel Ltd., a pharma company that specializes in developing, manufacturing and marketing progressive medical cannabis products and the German pharmaceutical company AxioNovo GmbH, specialized in the field of Oncology, announced the ...
Tris Pharma, Neuraxpharm Announce Partnership americanpharmaceuticalreview
December 28, 2020
Tris Pharma and Neuraxpharm Group have entered into an agreement whereby Neuraxpharm received exclusive rights to commercialize Tris' FDA-approved Quillivant XR and Quillichew ER in Europe.
Permira to acquire German pharma firm Neuraxpharm pharmaceutical-technology
September 27, 2020
Private equity firm Permira has agreed to acquire German speciality pharmaceutical company Neuraxpharm from Apax Partners.